- 20,22-DIHYDRODIGITOXIN
- 20,29,30-Trinorlupane,(17alpha)-
- 20-ETHYL-6-β,8-DIHYDROXY-1-α-METHOXY-4-METHYLHETERATISAN-14-ONE
- 20-Ethylprostaglandin F2-alpha
- 20-Isopropylcholanthrene
- 20-METHYLCHOLANTHREN-15-ONE
- 20-METHYLCHOLANTHRENE PICRATE
- 20-METHYLCHOLANTHRENE-TRINITRO-BENZENE
- 20(S)-Ginsenoside C-K
- 2,10-DIFLUOROBENZO(rst)PENTAPHENE
- 185346-17-2Pyridine,2,6-bis[(4R)-4-(1,1-dimethylethyl)-4,5-dihydro-2-oxazolyl]-
- 18534-66-2Cobinamide-Co(I),dihydrogen phosphate (ester), 3'-ester with 5,6-dimethyl-1-a-D-ribofuranosyl-1H-benzimidazole
- 18536-91-9Silane,dodecyltriethoxy-
- 185379-39-92-Pyridinepropanoicacid, a-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-,(aR)-
- 185379-40-22-Pyridinepropanoicacid, a-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-,(aS)-
- 185387-36-43-Azetidineacetic acid,2-carboxy-, (2S,3S)-
- 1853-99-2Benzamide,N-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-2-[2-(dimethylamino)ethoxy]-
- 18540-29-9Chromium, ion (Cr6+)
- 185411-12-54-Pentenoic acid,3-(trimethylsilyl)-, methyl ester
- 185412-89-91H-Benzimidazole,2,5,7-tris(trifluoromethyl)-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
2,6-Bis[(3aS,8aR)-3a,8a-dihydro-8H-indeno[1,2-d]oxazolin-2-yl]pyridine |
EINECS | N/A | ||||
| CAS No. | 185346-09-2 | Density | 1.50±0.1 g/cm3(Predicted) | ||||
| PSA | 56.07000 | LogP | 2.83840 | ||||
| Solubility | N/A | Melting Point |
265°C (dec.) |
||||
| Formula | C25H19N3O2 | Boiling Point | 633.0±55.0 °C(Predicted) | ||||
| Molecular Weight | 393.44 | Flash Point | N/A | ||||
| Transport Information | N/A | Appearance | N/A | ||||
| Safety |
|
Risk Codes | 36/37/38 | ||||
| Molecular Structure |
|
Hazard Symbols | N/A | ||||
| Synonyms |
(-)-2,6-BIS[2-[3AS-(2(3’AR*,8’AS*),3A,8A)-3A,8A-DIHYDRO-8H-INDENO[1,2-D]OXAZOLE]]PYRIDINE;2,6-BIS((3AS,8AR)-8H-INDENO(1,2-D)OXAZO&;(-)-2,6-Bis[2-{3aS-(2(3’aR*,8’aS*),3aalpha,8aalpha)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole}]pyridine,min.97%;(3aS,8aR)-in-pybox, (3aS,3μaS,8aR,8μaR)-2,2μ-(2,6-Pyridinediyl)bis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole;2,6-Bis[(3aS,8aR)-3a,8a-dihydro-8H-indeno[1,2-d]oxazolin-2-yl]pyridine;(-)-2,6-Bis[2-{3aS-(2(3’aR*,8’aS*),3aalpha:,8aalpha:)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole}]pyridine, min. 97% |
Article Data | 5 |
2,6-Bis[(3aS,8aR)-3a,8a-dihydro-8H-indeno[1,2-d]oxazolin-2-yl]pyridine Chemical Properties
Molecular Structure of 2,6-Bis[(3aS,8aR)-3a,8a-dihydro-8H-indeno[1,2-d]oxazolin-2-yl]pyridine (CAS No.185346-09-2):
Molecular Formula: C25H19N3O2
Molecular Weight: 393.44
CAS No: 185346-09-2
2,6-Bis[(3aS,8aR)-3a,8a-dihydro-8H-indeno[1,2-d]oxazolin-2-yl]pyridine Safety Profile
Risk Statements: 36/37/38
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-36/37/39
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection.
What can I do for you?
Get Best Price
